Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 1.00 |
| ▸ | CYP1A1 | P04798 | 3/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 3/20 | 1.00 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | PDE4A | P27815 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | KCNA3 | P22001 | 6/20 | 0.69 |
| ▸ | MAPT | P10636 | 1/20 | 0.68 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.63 |
| ▸ | THRB | P10828 | 1/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Khellin SCHEMBL30839911 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP1A1HPGDMAPK1CYP1A2 | |
| SCHEMBL3609628 | 0.90 | CYP3A4 (0.82) | CYP3A4CYP1A1HPGDMAPK1CYP1A2 | |
| SCHEMBL10300856 | 0.90 | CYP3A4 (0.82) | CYP3A4CYP1A1HPGDMAPK1CYP1A2 | |
| SCHEMBL13920849 | 0.90 | CYP3A4 (0.81) | CYP3A4CYP1A1HPGDMAPK1CYP1A2 | |
| SCHEMBL13920848 | 0.90 | CYP3A4 (0.81) | CYP3A4CYP1A1HPGDMAPK1CYP1A2 | |
| SCHEMBL1343992 | 0.88 | CYP3A4 (0.78) | CYP3A4CYP1A1HPGDMAPK1CYP1A2 | |
| SCHEMBL1344606 | 0.88 | CYP3A4 (0.78) | CYP3A4CYP1A1HPGDMAPK1CYP1A2 | |
| SCHEMBL12133429 | 0.88 | CYP3A4 (0.77) | CYP3A4CYP1A1HPGDMAPK1CYP1A2 | |
| SCHEMBL12132138 | 0.87 | CYP1A1 (0.76) | CYP3A4CYP1A1HPGDMAPK1CYP1A2 | |
| SCHEMBL1344680 | 0.87 | CYP3A4 (0.76) | CYP3A4CYP1A1HPGDMAPK1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 35401 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECH INC (US) | 2026-04-09 | — | — | US | claimed |
| EP-4580751-A2 | STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | Adora Animal Health Corporation (US) | 2025-07-09 | — | — | EP | claimed |
| US-12303528-B2 | Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions | ADORA ANIMAL HEALTH CORPORATION (US) | 2025-05-20 | — | — | US | claimed |
| EP-4496476-A1 | GAS PHASE TREATMENT OF PRODUCE | Apeel Technology, Inc. (US) | 2025-01-29 | — | — | EP | claimed |
| US-20240342208-A1 | STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | ADORA LIFE SCIENCE, INC. | 2024-10-17 | — | — | US | claimed |
| US-20240238278-A1 | Pharmaceutical Composition for Preventing or Treating Fibrosis | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 2024-07-18 | — | — | US | claimed |
| CN-118354793-A | Methods and compositions for treating eosinophil-driven diseases and conditions | 普瑞诺生物科技公司 | 2024-07-16 | — | — | CN | claimed |
| US-20240228540-A1 | COMPOSITIONS AND METHODS FOR TREATING ENDOMETRIOSIS | ENDOMET BIOSCIENCES, INC. | 2024-07-11 | — | — | US | claimed |
| US-20240228583-A1 | ACTIVIN RECEPTOR TYPE II CHIMERAS AND METHODS OF USE THEREOF | KEROS THERAPEUTICS, INC. | 2024-07-11 | — | — | US | claimed |
| US-20240216316-A1 | DIHOMO-GAMMA LINOLENIC ACID (DGLA) IS A NOVEL SENOLYTIC | BUCK INST RES AGING (US) | 2024-07-04 | — | — | US | claimed |
| EP-0339054-A1 | MIXTURE OF SUBSTANCES FOR STABILYZING METABOLISM. | BILAS ANDOR | 1989-11-02 | — | — | EP | claimed |
| EP-0328255-A1 | A medicament for the treatment of a fibrotic disorder, and anti-fibrotic composition | BAKER CUMMINS DERMATOLOGICALS, INC. (US) | 1989-08-16 | — | — | EP | claimed |
| WO-1989003213-A1 | MIXTURE OF SUBSTANCES FOR STABILYZING METABOLISM | BILAS ANDOR (AT) | 1989-04-20 | — | — | WO | claimed |
| EP-0308500-A1 | HUMAN SOMATOMEDIN CARRIER PROTEIN SUBUNITS AND PROCESS FOR PRODUCING THEM. | BIOGROWTH INC (US) | 1989-03-29 | — | — | EP | claimed |
| EP-0301371-A2 | Benzofuran carboxamides with basic substituents, process for their preparation and therapeutical compositions containing them | BASF Aktiengesellschaft (DE) | 1989-02-01 | — | — | EP | claimed |
| EP-0294021-A1 | Human somatomedin carrier protein subunits and process for producing them | BIOGROWTH, INC. (US) | 1988-12-07 | — | — | EP | claimed |
| WO-1988007863-A1 | HUMAN SOMATOMEDIN CARRIER PROTEIN SUBUNITS AND PROCESS FOR PRODUCING THEM | BIOGROWTH, INC. (US) | 1988-10-20 | — | — | WO | claimed |
| US-4524065-A | Method for the prevention and treatment of scars with enzymes | BIO-SPECIFICS N.V. (AN) | 1985-06-18 | — | — | US | claimed |
| US-4399146-A | Treatment of atherosclerosis with khellin-related furochromones | THE UPJOHN COMPANY (US) | 1983-08-16 | — | — | US | claimed |
| US-4281013-A | Antiatherosclerotic use of khellin and khellinin | THE UPJOHN COMPANY (US) | 1981-07-28 | — | — | US | claimed |